首页|氯氮平联合阿戈美拉汀改善精神分裂症患者阴性症状的疗效评价

氯氮平联合阿戈美拉汀改善精神分裂症患者阴性症状的疗效评价

扫码查看
目的 探讨氯氮平联合阿戈美拉汀改善精神分裂症患者阴性症状的疗效.方法 将69例精神分裂症患者按照随机数字表法分为研究组(35 例)和对照组(34 例).对照组患者给予氯氮平联合安慰剂治疗 12 周,研究组患者给予氯氮平联合阿戈美拉汀治疗 12 周.治疗前后,采用阳性和阴性症状量表(PANSS)、阴性症状量表(SANS)评估两组患者临床症状和阴性症状.结果 治疗后,研究组患者PANSS总分及一般精神病理症状、阴性症状评分较治疗前降低,且阴性症状评分低于对照组(P<0.01);研究组患者SANS评分较治疗前降低(P<0.01).结论 氯氮平联合阿戈美拉汀改善精神分裂症患者阴性症状疗效显著,临床应用潜力较好.
Curative effect of clozapine plus agomelatine in the treatment of negative symptoms of schizophrenia
Objective To explore the curative effect of clozapine plus agomelatine in the treatment of negative symptoms of schizophrenia.Methods Sixty-nine schizophrenics were assigned to research(n=35)and control(n=34)group according to random number table method.Controls received clozapine plus placebo treatment and research group did clozapine plus agomelatine for 12 weeks.Before and after treatment,clinical and negative symptoms were assessed for both groups using the Positive and Negative Syndrome Scale(PANSS)and Scale for the Assessment of Negative Symptoms(SANS)respectively.Results After treatment,the total,general psychopathological and negative symptom score of the PANSS lowered compared with pre-treatment in research group,score on the negative symptom was lower in research than control group(P<0.01),SANS score was lower in research group compared with pre-treatment(P<0.01).Conclusion The combination of clozapine and agomelatine significantly improves negative symptoms of schizophrenics and has good potential for clinical application.

agomelatineschizophrenianegative symptomscurative effect

沈文超、吴贻明、宋兵福、郑琰婷

展开 >

200093(中国·上海)上海市杨浦区精神卫生中心

阿戈美拉汀 精神分裂症 阴性症状 疗效

2025

临床心身疾病杂志
河南省精神病医院(新乡医学院第二附属医院)

临床心身疾病杂志

影响因子:1.01
ISSN:1672-187X
年,卷(期):2025.31(1)